WeWork and co-founder Adam Neumann reached a legal settlement with SoftBank Group that will cement control of the embattled real estate start-up with its largest investor and send the former chief executive on his way with a financial windfall.
The pact announced Friday, February 26, ends a legal fight over a stock transaction that collapsed and eliminates the need for a March 4 trial in Delaware. Terms of the settlement weren’t disclosed.
According to people familiar with the agreement, Neumann will give up for a year his role on the board of the co-working company he helped create, while cashing out roughly US$480 million in stock to SoftBank. Additionally, SoftBank will pay Neumann US$50 million to cover legal fees and another US$50 million as part of a non-compete fee he was previously promised, as well as giving him a five-year extension on a US$430-million loan he owes the Japanese investor.
Neumann can ask for a return to the board as an observer or designate someone in his place, but either request would require SoftBank’s approval, Bloomberg previously reported.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas